Serum concentrations of DKK-1 correlate with the extent of bone disease in multiple myeloma

被引：0
|
作者：
Kaiser, Martin [1 ]
Mieth, Maren [1 ]
Liebisch, Peter [2 ]
Rotzer, Susanne [1 ]
Peters, Malte [1 ,4 ]
Sezer, Orhan [1 ]
Heider, Ulrike [1 ]
Jakob, Christian
Fleissner, Claudia [1 ]
Braendle, Edgar [3 ]
Stover, David [3 ]
机构：
[1] Univmed Berlin, Dept Hematol & Oncol, Berlin, Germany
[2] Univ Ulm Klinikum, Innere Med Klin 3, Ulm, Germany
[3] Novartis Inst Biomed Res, Cambridge, MA USA
[4] Novartis Pharmaceut, Basel, Switzerland
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.3518.3518
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3518
引用
收藏
页码：1030A / 1030A
页数：1
相关论文
共 50 条
  • [1] Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma
    Kaiser, Martin
    Mieth, Maren
    Liebisch, Peter
    Oberlaender, Romy
    Rademacher, Jessica
    Jakob, Christian
    Kleeberg, Lorenz
    Fleissner, Claudia
    Braendle, Edgar
    Peters, Malte
    Stover, David
    Sezer, Orhan
    Heider, Ulrike
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 80 (06) : 490 - 494
  • [2] Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment
    Heider, Ulrike
    Kaiser, Martin
    Mieth, Maren
    Lamottke, Britta
    Rademacher, Jessica
    Jakob, Christian
    Braendle, Edgar
    Stover, David
    Sezer, Orhan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (01) : 31 - 38
  • [3] Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease
    Eda, Homare
    Santo, Loredana
    Wein, Marc N.
    Hu, Dorothy Z.
    Cirstea, Diana D.
    Nemani, Neeharika
    Tai, Yu-Tzu
    Raines, Sarah E.
    Kuhstoss, Stuart Allen
    Munshi, Nikhil C.
    Kronenberg, Henry M.
    Raje, Noopur S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2016, 31 (06) : 1225 - 1234
  • [4] Inhibiting Dickkopf-1 (Dkk-1) prevents the development of osteolytic bone disease in multiple myeloma
    Heath, D. J.
    Chantry, A. D.
    Buckle, C.
    Coulton, L.
    Shaughnessy, J. D., Jr.
    Evans, H.
    Stover, D. R.
    Vanderkerken, K.
    Croucher, P. I.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 83 (01) : 6 - 6
  • [5] Inhibiting dickkopf-1 (Dkk-1) prevents the development of osteolytic bone disease in multiple myeloma
    Heath, Debby
    Chantry, Andrew
    Buckle, Clive
    Coulton, Les
    Shaughnessy, John, Jr.
    Evans, Holly
    Stover, David
    Vanderkerken, Karin
    Croucher, Peter
    CANCER TREATMENT REVIEWS, 2008, 34 : S52 - S52
  • [6] Preclinical Validation of a Novel Dkk-1 Neutralizing Antibody for the Treatment of Multiple Myeloma Related Bone Disease.
    Pozzi, S.
    Yan, H.
    Vallet, S.
    Vaghela, N.
    Cirstea, D.
    Santo, L.
    Mukheriee, S.
    Hideshima, T.
    Schirtzinger, L.
    Kuhstoss, S.
    Anderson, K. C.
    Scadden, D.
    Raje, N.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S300 - S300
  • [7] SERUM LEVELS OF MACROPHAGE COLONY STIMULATING FACTOR CORRELATE WITH THE EXTENT OF BONE DISEASE IN PATIENTS WITH MULTIPLE MYELOMA
    Gressier, Melanie
    Salle, Valery
    Blanpain, Sebastien
    Brazier, Michel
    Kamel, Said
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S245 - S245
  • [8] Promoting Osteoblastogenesis Using a Novel Dkk-1 Neutralizing Antibody in the Treatment of Multiple Myeloma Related Bone Disease.
    Pozzi, Samantha
    Yan, Hua
    Vallet, Sonia
    Vaghela, Nileshwari
    Fulciniti, Mariateresa
    Cirstea, Diana
    Santo, Loredana
    Mukherjee, Siddhartha
    Hideshima, Teru
    Schirtzinger, Linda
    Kuhstoss, Stuart
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Scadden, David
    Raje, Noopur
    BLOOD, 2008, 112 (11) : 946 - 946
  • [9] Bone Marrow DKK-1 Levels Identify Patients With Smoldering Myeloma With Higher Risk of Progression to Active Multiple Myeloma
    Giuliani, Nicola
    Palma, Benedetta Dalla
    Marchica, Valentina
    Accardi, Fabrizio
    Notarfranchi, Laura
    Costa, Federica
    De Luca, Federica
    Guasco, Daniela
    Pedrazzoni, Mario
    Aversa, Franco
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E35 - E35
  • [10] Source of serum Dkk-1 in breast cancer patients with bone metastases
    Journe, F.
    Kheddoumi, N.
    Voorzanger-Rousselot, N.
    Doriath, V.
    Garnero, P.
    Body, J.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 40 - 41
12345